Funding for this research was provided by:
Else Kröner-Fresenius-Stiftung (216A133)
Text and Data Mining valid from 2019-03-29
Received: 25 January 2019
Accepted: 14 March 2019
First Online: 29 March 2019
Ethics approval and consent to participate
: The study protocol was approved by the leading ethics committee (Ethik-Kommission Albert-Ludwigs-Universität Freiburg, ethics approval number 174/17(FF-MC)) and the local ethics committees. A complete list of the committees that approved the study is given in the Supplementary Material (see Additional file InternalRef removed:Table S1). Written informed consent for trial participation has been/is obtained from all participants before entering the MARTA trial. Recruitment started in September 2017.
: Not applicable.
: ES, JF and GI receive speakers’ honoraries from Riemser Pharma GmbH. All other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.